Showing results (271-280 of 280) with videos related to
Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 280 results.
Nature Communications|July 10, 2024
Bioengineered niches that recreate physiological extracellular matrix organisation to support long-term haematopoietic stem cellsHannah Donnelly, Ewan Ross, Yinbo Xiao, et al.The New England Journal of Medicine|March 27, 2012
Vorapaxar in the secondary prevention of atherothrombotic eventsDavid A Morrow, Eugene Braunwald, Marc P Bonaca, et al.Circulation|July 16, 2013
Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrelMatthew T Roe, Shaun G Goodman, E Magnus Ohman, et al.Nature Communications|February 10, 2023
Nanotopography reveals metabolites that maintain the immunomodulatory phenotype of mesenchymal stromal cellsEwan A Ross, Lesley-Anne Turner, Hannah Donnelly, et al.Microbiome Research Reports|April 10, 2025
Profiling the gut and oral microbiota of hormone receptor-positive, HER2-negative metastatic breast cancer patients receiving pembrolizumab and eribulinNancy My Teng, Andrea Malfettone, Matthew J Dalby, et al.JAMA Cardiology|July 21, 2016
Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events: A Secondary Analysis of the PEGASUS-TIMI 54 TrialMarc P Bonaca, Deepak L Bhatt, Ton Oude Ophuis, et al.Circulation|May 5, 2022
Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 TrialRemo H M Furtado, Itamar Raz, Erica L Goodrich, et al.Circulation|May 24, 2019
Effect of Alirocumab on Mortality After Acute Coronary SyndromesPhilippe Gabriel Steg, Michael Szarek, Deepak L Bhatt, et al.The New England Journal of Medicine|August 28, 2012
Prasugrel versus clopidogrel for acute coronary syndromes without revascularizationMatthew T Roe, Paul W Armstrong, Keith A A Fox, et al.The New England Journal of Medicine|April 1, 2014
Darapladib for preventing ischemic events in stable coronary heart disease, Harvey D White, Claes Held, et al.Pageof 28